Table 3.

Univariate and Multivariate analysis of potential molecular markers for overall survival of hepatoblastoma

	Univariate	P	Multivariate HR (95%CI)*	P
Preoperative chemotherapy
(yes versus no)	1.36(0.89-3.79)	0.046	2.16(0.91-5.11)	0.074
surgical resection
(yes versus no)	1.81(0.92-3.62)	0.082	2.13(1.17-4.43)	0.033
Gli1 expression
(positive versus negative)	4.75(1.16-15.61)	0.011	6.34(1.35-18.86)	0.007
Patched expression
(positive versus negative)	2.53(0.81-5.86)	0.161	3.12(0.93-6.45)	0.084

* Adjusted for tumor grade, histologic type, and stage classification